全国服务咨询热线：
18438616290
18438616290
产品分类
Product Category详细介绍
| 品牌 | absin | CAS | 115436-72-1 |
|---|---|---|---|
| 分子式 | C7H10NO7P2 • Na | 纯度 | 99% |
| 分子量 | 305.09 | 货号 | abs47027462 |
| 规格 | 25mg | 供货周期 | 现货 |
| 主要用途 | used in the treatment of osteoporosis | 应用领域 | 化工,生物产业,农林牧渔,制药/生物制药,综合 |
Risedronate Sodium 115436-72-1
| 产品描述 | |
| 描述 | Risedronate Sodium, a nitrogen-containing bisphosphonate, inhibits osteoclast-mediated bone resorption and modulates bone metabolism, used in the treatment of osteoporosis. |
| 纯度 | 99% |
| 储存/保存方法 | Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 别名 | 利sai膦酸钠；Risedronic Acid Sodium |
| 外观 | 白色或类白色结晶性粉末 |
| 可溶性/溶解性 | water : 3.1 mg/mL (10 mM) |
| 生物活性 | |
| 靶点 | FPS,HAP |
| In vitro(体外研究) | Risedronate causes a total inhibition of colony formation whereas Etidronate has relatively little effect in calcifying fibroblastic colony-forming unit (CFU-f) cultures of rat bone marrow cells in vitro. Risedronate (1 μM) decreases the formation of colonies displaying osteoblastic characteristics such as alkaline phosphatase expression, collagen accumulation, and calcification. Risedronate (1 nM) and alendronate increases the formation of fibroblastic colonies, suggesting a mild anabolic effect, however, the formation of colonies with osteoblastic properties is not affected. Risedronate significantly inhibits expression of c-Fos and nuclear factor of activated T cells (NFAT) c1 induced by RANKL in bone marrow-derived macrophages (BMMs). |
| In vivo(体内研究) | Risedronate (1 mg/kg) significantly increases the volumetric densities of bone (Vb) and osteoblast Vob and decreases Vm more prominently in rats. Risedronate causes a significant and dose-dependent reduction of tooth movement after the orthodontic force is applied in rats. Risedronate prevents a reduction in periosteal bone formation and an increase in endocortical bone erosion, resulting in prevention of alterations in percent cortical bone and marrow areas. Risedronate increases osteocyte density and lacunar occupancy and prevented a GC-induced increase in cortical porosity. Risedronate and Vitamin K(2) has additive effects on osteocyte density and lacunar occupancy and a synergistic effect on cortical porosity. |
| 参考文献 | |
| 参考文献 |
|
| 研究领域 | |
| 研究领域 | Drug DiscoverySmall Molecule DrugLead Compound Discovery |
产品咨询
地址：上海市浦东新区新浩路58号申江科创园18栋
邮箱：lanwu@univ-bio.com
传真：